Roy Luo - Net Worth and Insider Trading
Roy Luo Net Worth
The estimated net worth of Roy Luo is at least $81 Million dollars as of 2024-06-05. Roy Luo is the Director of Enfusion Inc and owns about 9,009,594 shares of Enfusion Inc (ENFN) stock worth over $81 Million. Details can be seen in Roy Luo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Roy Luo has not made any transactions after 2021-10-25 and currently still holds the listed stock(s).
Transaction Summary of Roy Luo
Roy Luo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Roy Luo owns 1 companies in total, including Enfusion Inc (ENFN) .
Click here to see the complete history of Roy Luo’s form 4 insider trades.
Insider Ownership Summary of Roy Luo
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENFN | Enfusion Inc | 2021-10-25 | director |
Roy Luo Latest Holdings Summary
Roy Luo currently owns a total of 1 stock. Roy Luo owns 9,009,594 shares of Enfusion Inc (ENFN) as of October 25, 2021, with a value of $81 Million.
Latest Holdings of Roy Luo
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENFN | Enfusion Inc | 2021-10-25 | 9,009,594 | 8.95 | 80,635,866 |
Holding Weightings of Roy Luo
Roy Luo Form 4 Trading Tracker
According to the SEC Form 4 filings, Roy Luo has made a total of 1 transactions in Enfusion Inc (ENFN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Enfusion Inc is the acquisition of 1,261,594 shares on October 25, 2021, which cost Roy Luo around $21 Million.
Insider Trading History of Roy Luo
- 1
Roy Luo Trading Performance
GuruFocus tracks the stock performance after each of Roy Luo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Roy Luo is -40.17%. GuruFocus also compares Roy Luo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Roy Luo within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Roy Luo's insider trading performs compared to the benchmark.
Performance of Roy Luo
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.09 | | | | | |
| Relative Return to S&P 500(%) | -18.05 | | | | | |
Roy Luo Ownership Network
Roy Luo Owned Company Details
What does Enfusion Inc do?
Who are the key executives at Enfusion Inc?
Roy Luo is the director of Enfusion Inc. Other key executives at Enfusion Inc include Chief People Officer Bronwen Bastone , director & 10 percent owner Oleg Movchan , and Chief Financial Officer Bradley Herring .
Enfusion Inc (ENFN) Insider Trades Summary
Over the past 18 months, Roy Luo made no insider transaction in Enfusion Inc (ENFN). Other recent insider transactions involving Enfusion Inc (ENFN) include a net sale of 115,220 shares made by Dan Groman , a net sale of 35,050 shares made by Bronwen Bastone , and a net sale of 252,650 shares made by Oleg Movchan .
In summary, during the past 3 months, insiders sold 34,059 shares of Enfusion Inc (ENFN) in total and bought 0 shares, with a net sale of 34,059 shares. During the past 18 months, 5,279,878 shares of Enfusion Inc (ENFN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,279,878 shares.
Enfusion Inc (ENFN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enfusion Inc Insider Transactions
Roy Luo Mailing Address
Above is the net worth, insider trading, and ownership report for Roy Luo. You might contact Roy Luo via mailing address: 394 Pacific Avenue, 2nd Floor, San Francisco Ca 94111.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
